• 1. Enantio- & chemo-selective preparation of enantiomerically enriched aliphatic nitro alcohols using Candida parapsilosis ATCC 7330
  Sowmyalakshmi Venkataraman RSC Adv., 2015,5, 73807-73813
• 2. Excited-state proton-coupled electron transfer within ion pairs?
  Gerald J. Meyer,Leif Hammarstr?m Chem. Sci., 2020,11, 3460-3473
• 3. Evolution study of photo-synthesized gold nanoparticles by spectral deconvolution model: a quantitative approach
  Chung-Sung Yang,Mong-Shian Shih,Fang-Yi Chang New J. Chem., 2006,30, 729-735
• 4. Excimer formation effects and trap-assisted charge recombination loss channels in organic solar cells of perylene diimide dimer acceptors?
  Min Kim,Jae-Joon Lee,Tengling Ye,Panagiotis E. Keivanidis,Kilwon Cho J. Mater. Chem. C, 2020,8, 1686-1696
• 5. Fate of Sb(v) and Sb(iii) species along a gradient of pH and oxygen concentration in the Carnoulès mine waters (Southern France)
  Eléonore Resongles,Corinne Casiot,Fran?oise Elbaz-Poulichet,Rémi Freydier,Odile Bruneel,Christine Piot,Sophie Delpoux,Aurélie Volant,Angélique Desoeuvre Environ. Sci.: Processes Impacts, 2013,15, 1536-1544

Introduction to 2-Cyano-5-(3,5-dicarboxyphenyl)phenol (CAS No. 1261954-11-3)

2-Cyano-5-(3,5-dicarboxyphenyl)phenol, identified by the Chemical Abstracts Service Number (CAS No.) 1261954-11-3, is a specialized organic compound that has garnered significant attention in the field of chemical biology and pharmaceutical research. This compound, featuring a cyano group and two carboxylic acid functionalities at the 3 and 5 positions of a phenyl ring, presents a unique structural framework that makes it a promising candidate for various biochemical applications.

The molecular structure of 2-Cyano-5-(3,5-dicarboxyphenyl)phenol consists of a central benzene ring substituted with a cyano group at the 2-position and two carboxylic acid groups at the 3 and 5 positions. This arrangement imparts distinct chemical properties, including reactivity towards nucleophilic substitution and coordination with metal ions, which are highly relevant in drug design and catalysis. The presence of multiple functional groups also allows for further derivatization, enabling the synthesis of more complex molecules with tailored biological activities.

In recent years, 2-Cyano-5-(3,5-dicarboxyphenyl)phenol has been studied for its potential in medicinal chemistry, particularly as a precursor in the development of novel therapeutic agents. The cyano group can be hydrolyzed to form a carboxylic acid, while the carboxylic acid groups can be used to form esters or amides, facilitating the creation of bioactive molecules. Additionally, the compound's ability to chelate with transition metals has been explored in the context of metal-organic frameworks (MOFs) and catalytic systems.

One of the most intriguing aspects of 2-Cyano-5-(3,5-dicarboxyphenyl)phenol is its potential role in modulating biological pathways. Research has suggested that derivatives of this compound may exhibit inhibitory effects on certain enzymes and receptors, making them valuable candidates for treating inflammatory diseases, cancer, and neurological disorders. For instance, studies have shown that analogs with similar structural motifs can interfere with key signaling pathways involved in cell proliferation and apoptosis.

The synthesis of 2-Cyano-5-(3,5-dicarboxyphenyl)phenol involves multi-step organic reactions that require precise control over reaction conditions. Typically, it is synthesized from readily available aromatic precursors through cyanation and carboxylation reactions. Advanced synthetic techniques such as palladium-catalyzed cross-coupling reactions have also been employed to achieve higher yields and purities. The optimization of these synthetic routes is crucial for ensuring scalability and cost-effectiveness in pharmaceutical applications.

The pharmacological properties of 2-Cyano-5-(3,5-dicarboxyphenyl)phenol have been investigated both in vitro and in vivo. Preliminary studies have demonstrated its ability to interact with biological targets such as kinases and transcription factors. For example, derivatives of this compound have shown promise in inhibiting Janus kinases (JAKs), which are implicated in autoimmune diseases like rheumatoid arthritis. Furthermore, its metal-chelating properties have led to research into its potential as an anticancer agent by disrupting metal-dependent processes in tumor cells.

Another area where 2-Cyano-5-(3,5-dicarboxyphenyl)phenol has shown promise is in the development of imaging agents. The ability to incorporate radioactive isotopes or fluorescent dyes into derivatives of this compound could lead to novel contrast agents for medical imaging techniques such as positron emission tomography (PET) and fluorescence microscopy. Such applications could enhance diagnostic capabilities by providing more detailed insights into disease mechanisms at the molecular level.

The environmental impact of 2-Cyano-5-(3,5-dicarboxyphenyl)phenol is also an important consideration in its development and application. Efforts are being made to ensure that synthetic processes are sustainable and that any byproducts are safely managed. Green chemistry principles are being applied to minimize waste and reduce energy consumption during production. Additionally, research is ongoing into biodegradability studies to assess the ecological footprint of this compound.

Future directions for research on 2-Cyano-5-(3,5-dicarboxyphenyl)phenol include exploring its potential in combination therapies and developing novel formulations for improved bioavailability. Computational modeling techniques are being used to predict how different derivatives might interact with biological targets, accelerating the discovery process. Collaborative efforts between academia and industry are essential to translate laboratory findings into clinical applications that benefit patients worldwide.

In conclusion,2-Cyano-5-(3,5-dicarboxyphenyl)phenol (CAS No. 1261954-11-3) represents a fascinating compound with diverse applications in pharmaceuticals, catalysis, and materials science. Its unique structural features offer opportunities for innovation across multiple disciplines. As research continues to uncover new possibilities for this molecule,2-Cyano-5-(3,5-dicarboxyphenyl)phenol is poised to play an increasingly important role in advancing scientific understanding and developing next-generation therapeutics.

• 1261964-24-2(Methyl 4-(3-cyano-4-hydroxyphenyl)benzoate)
• 1261986-06-4(2-Cyano-5-(3-methoxycarbonylphenyl)phenol)
• 1261964-14-0(2-Cyano-4-(3-methoxycarbonylphenyl)phenol)
• 1261987-38-5(2-Cyano-4-(3,5-dicarboxyphenyl)phenol)
• 1261998-90-6(2-Cyano-5-(4-methoxycarbonylphenyl)phenol)
• 1261894-54-5(2-Cyano-5-(4-formylphenyl)phenol)
• 1258618-99-3(3-(4-Cyanophenyl)-5-hydroxybenzoic acid)
• 1261931-47-8(2-Cyano-5-(3-formylphenyl)phenol)
• 1258637-09-0(3-(3-Cyanophenyl)-5-hydroxybenzoic acid)
• 70829-28-6(3-Cyano-4-hydroxybenzoic acid)